GMP Update: Reducing Obstacles to Innovation

FDA offers new policies to encourage modern manufacturing approaches and automated systems, to simplify postapproval changes, and to avoid problems with sterile products.


For full article
Click Here






Author(s): 
Jill Wechsler.
Journal: 
Pharmaceutical Technology, Oct 2, 2003.